Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Megan Philippa Hitchins

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3603-2309; OpenAlex author ID A5083863816. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program. First author DOI 10.1016/j.hpb.2024.05.005↗
  2. Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma. First author DOI 10.21037/jgo-23-12↗
  3. Pancreatic cancer 'mismatch' in Lynch syndrome. Last author DOI 10.1136/bmjgast-2019-000274↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Eugene Hendifar · 3 shared papers, 2019–2024 · strength 0.64
  2. Matthew Ebia · 1 shared paper, 2023 · strength 0.31
  3. Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.23
  4. Arsen Osipov · 1 shared paper, 2024 · strength 0.23
  5. Brent K. Larson · 1 shared paper, 2019 · strength 0.10
  6. Michelle Guan · 1 shared paper, 2019 · strength 0.10
  7. Richard Tuli · 1 shared paper, 2019 · strength 0.10
  8. Jun Gong · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.